Preliminary results from a late-stage trial involving adults with obesity and knee osteoarthritis showed average weight loss of about 28.7% after 68 weeks, suggesting the drug may be even more effective than earlier treatments
While GLP-1 therapies have significantly improved the management of both DM2 and obesity, several challenges remain, including patient variability in response, gastrointestinal side effects, cost considerations, and long-term adherence
Notably, persistent (i.e., drug-tolerant) cancer cells are particularly vulnerable to GPX4 inhibitors
retatrutide uses a single novel molecule targeting three receptors
(PubMed) Parvanova A, Trillini M, Podesta MA, et al
A liposome is a tiny, microscopic sphere made of phospholipids the same healthy fats that make up your own cell membranes